Biolex Therapeutics' Death

Biolex Therapeutics raised a round of funding on July 06, 2012. Investors include Dead.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics' Death: